Crescent Capital Consulting »

GlaxoSmithKline shares owned by Crescent Capital Consulting

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Crescent Capital Consulting from 13F filings

Historical chart of Crescent Capital Consulting investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Crescent Capital Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Crescent Capital Consulting

Quarter filed Position value Share count Share price at filing
2021-12-31 $99k 2.2k 44.59
2021-09-30 $85k 2.2k 38.71
2021-06-30 $91k 2.3k 39.22
2021-03-31 $81k 2.4k 33.33
2020-12-31 $0 2.0k 0.00

More positions owned by Crescent Capital Consulting

iShares Russell 1000 Gr Exchange Traded Fund (IWF)
Bk Of America Corp Cll Opt 01/23 37.0 Cal Call (BAC)
Automatic Data Processin Cll Opt 02/22 250.0 Cal Call (ADP)
iShares Core S&P 500 Exchange Traded Fund (IVV)
Invesco Bulletshares 2023 HY Corp Bd Exchange Traded Fund
Invesco Bulletshares 2022 HY Bd Exchange Traded Fund
Freeport Mcmoran Copper Common Stock (FCX)
Vanguard Russell 1000 Gr Exchange Traded Fund (VONG)
iShares Russell 1000 Val Exchange Traded Fund (IWD)
iShares S&P 500 Growth Exchange Traded Fund (IVW)
iShares TIPS Exchange Traded Fund (TIP)
Invesco Dynamic Semiconductors Exchange Traded Fund (PSI)
Vanguard Russell 1000 Val Exchange Traded Fund (VONV)
Invesco Bulletshares 2024 HY Corp Bd Exchange Traded Fund (BSJO)
Vanguard FTSE Europe Exchange Traded Fund (VGK)

View all positions for Crescent Capital Consulting

Top funds holding GlaxoSmithKline

Kahn Brothers Group
Damian Sousa
Columbia Asset Management
Paradigm Asset Management Company
Park Circle
Byrne Asset Management
Huntington National Bank

View all funds holding GlaxoSmithKline